Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest encephalomyelitis Stories

2014-01-22 16:26:11

WASHINGTON, Jan. 22, 2014 /PRNewswire-USNewswire/ -- A young man is taking on the medical establishment with a plan to educate medical students about the devastating disease Chronic Fatigue Syndrome, also known as Myalgic Encephalomyelitis, that is little or not understood at all by most doctors. Ryan Prior, 24, has Chronic Fatigue Syndrome, which affects about 1 million Americans and 17 million people around the world. Prior, accompanied by infectious disease researcher Dr. Andreas...

2013-12-27 10:35:21

Researchers at Oregon Health & Science University have discovered that an antioxidant designed by scientists more than a dozen years ago to fight damage within human cells significantly helps symptoms in mice that have a multiple sclerosis-like disease. The antioxidant — called MitoQ — has shown some promise in fighting neurodegenerative diseases. But this is the first time it has been shown to significantly reverse an MS-like disease in an animal. The discovery could lead to an...

2013-11-20 08:29:08

First-time filmmaker Jennifer Brea offers firsthand insights into daily effects of M.E. PRINCETON, N.J., Nov. 20, 2013 /PRNewswire/ -- It turned out to be the beginning of a long illness -- including neurological dysfunction and extreme exhaustion -- that she has yet to recover from. When the medical community did not recognize her illness and worse, dismissed it as hysteria, Brea did her own research and discovered that there is a name for what she was experiencing: Myalgic Encephalomyelitis...

2013-10-01 15:39:41

Researchers discourage supplemental use by patients with multiple sclerosis, according to report in the American Journal of Pathology Resveratrol, a naturally occurring polyphenol compound produced by the skin of red grapes and peanuts, and found in red wine, has been touted as a beneficial supplement due to its anti-inflammatory and antioxidant properties. This has been supported by some experimental studies, whereas others suggest a lack of benefit. A new study using two multiple...

2013-01-31 12:28:04

GLEN ALLEN, Va., Jan. 31, 2013 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI) today announces publication of the first peer-reviewed article examining the effects of anatabine in a mouse model of the debilitating autoimmune and neurodegenerative disease multiple sclerosis (MS). The study, conducted by the Company's research partner, The Roskamp Institute, was designed to determine whether anatabine had beneficial effects on the development of experimental autoimmune encephalomyelitis...

2012-10-16 11:25:42

GLEN ALLEN, Va., Oct. 16, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI) through its wholly owned subsidiary, Rock Creek Pharmaceuticals Inc., reports that earlier in the week scientists from its research partner, the Roskamp Institute, presented results of its recent research showing that anatabine supplementation significantly reduces central and peripheral inflammation and neurological injury in an animal model of multiple sclerosis (MS). The findings were presented in New...

2012-05-29 02:27:35

CHICAGO, May 29, 2012 /PRNewswire/ -- The International Association for Chronic Fatigue Syndrome and Myalgic Encephalomyelitis (IACFS/ME), the largest group of physicians and researchers dedicated to chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME), has released updated care guidelines directed at primary care physicians and other health care providers. The document, "Chronic Fatigue Syndrome Myalgic Encephalomyelitis: A Primer for Clinical Practitioners," can be accessed at:...

2009-07-23 08:45:00

Dr. Feng Lin and colleagues at Case Western Reserve University in Cleveland, OH have discovered that the complement inhibitor FUT-175 delays EAE onset. They present these findings in the August 2009 issue of The American Journal of Pathology.Multiple sclerosis (MS) is an autoimmune disease in which the body's immune response attacks the central nervous system (CNS), causing physical and cognitive disability. Complement, molecules involved in clearing infection, may enhance this misguided...

2009-04-02 08:00:00

CHARLOTTESVILLE, Virginia, April 2 /PRNewswire/ -- Biovista Inc. today announced that BVA-101, its drug targeting Multiple Sclerosis (MS), has shown significant positive results in the MOG-induced Experimental Allergic Encephalomyelitis (EAE) murine model of MS. BVA-101, an existing drug that Biovista repositioned in MS and is aimed at neuroprotection, was shown to have both efficacy in reducing symptoms and no toxic effects in this well established model of MS. "We are excited about...

2008-02-13 03:00:15

By Wong, Kum Thong Munisamy, Badmanathan; Ong, Kien Chai; Kojima, Hideaki; Noriyo, Nagata; Chua, Kaw Bing; Ong, Beng Beng; Nagashima, Kazuo Abstract Previous neuropathologic studies of Enterovirus 71 encephalomyelitis have not investigated the anatomic distribution of inflammation and viral localization in the central nervous system (CNS) in detail. We analyzed CNS and non-CNS tissues from 7 autopsy cases from Malaysia and found CNS inflammation patterns to be distinct and stereotyped....